Knowledge (XXG)

Template:Nonsympatholytic vasodilatory antihypertensives

Source 📝

37: 30: 173: 158: 216: 295: 190: 123: 178: 147: 15: 83: 72: 63: 50: 220: 184: 289: 230: 98: 113: 54: 47: 108: 103: 92: 137: 132: 258:
will show the template collapsed, i.e. hidden apart from its title bar.
223:), it is hidden apart from its title bar; if not, it is fully visible. 215:, meaning that if there is another collapsible item on the page (a 19: 282:
will show the template expanded, i.e. fully visible.
261: 237: 146: 122: 82: 62: 226:To change this template's initial visibility, the 266:Nonsympatholytic vasodilatory antihypertensives 242:Nonsympatholytic vasodilatory antihypertensives 31: 8: 38: 24: 16: 210:initial visibility currently defaults to 227: 7: 221:table with the collapsible attribute 14: 1: 312: 168: 124:Potassium channel openers 148:Calcium channel blockers 66:(arterioles and venules) 296:Drug templates by ATC 84:Hydrazinophthalazines 195:Never to phase III 205: 204: 51:antihypertensives 46:Nonsympatholytic 303: 281: 280: 276: 273: 270: 267: 264: 257: 256: 252: 249: 246: 243: 240: 229: 228:|state= 213: 208:This template's 64:Nitrovasodilator 40: 33: 26: 17: 311: 310: 306: 305: 304: 302: 301: 300: 286: 285: 278: 274: 271: 268: 265: 262: 254: 250: 247: 244: 241: 238: 217:navbox, sidebar 211: 206: 201: 200: 185:Clinical trials 164: 142: 118: 78: 58: 44: 12: 11: 5: 309: 307: 299: 298: 288: 287: 284: 283: 259: 203: 202: 199: 198: 197: 196: 193: 182: 176: 170: 169: 166: 165: 163: 162: 153: 151: 144: 143: 141: 140: 135: 129: 127: 120: 119: 117: 116: 111: 106: 101: 96: 89: 87: 80: 79: 77: 76: 69: 67: 60: 59: 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 308: 297: 294: 293: 291: 260: 236: 235: 234: 233:may be used: 232: 224: 222: 218: 214: 194: 192: 189: 188: 186: 183: 180: 177: 175: 172: 171: 167: 161: 160: 155: 154: 152: 149: 145: 139: 136: 134: 131: 130: 128: 125: 121: 115: 112: 110: 107: 105: 102: 100: 99:Dihydralazine 97: 94: 91: 90: 88: 85: 81: 74: 73:Nitroprusside 71: 70: 68: 65: 61: 56: 52: 49: 41: 36: 34: 29: 27: 22: 21: 18: 225: 212:autocollapse 209: 207: 156: 150:(arterioles) 126:(arterioles) 114:Pildralazine 86:(arterioles) 48:vasodilatory 23: 181:from market 109:Cadralazine 104:Endralazine 93:Hydralazine 253:collapsed 231:parameter 191:Phase III 179:Withdrawn 138:Diazoxide 133:Minoxidil 290:Category 277:expanded 174:WHO-EM 272:state 248:state 219:, or 159:list 157:see 55:C02 292:: 279:}} 263:{{ 255:}} 239:{{ 187:: 275:= 269:| 251:= 245:| 95:# 75:# 57:) 53:( 39:e 32:t 25:v

Index

v
t
e
vasodilatory
antihypertensives
C02
Nitrovasodilator
Nitroprusside
Hydrazinophthalazines
Hydralazine
Dihydralazine
Endralazine
Cadralazine
Pildralazine
Potassium channel openers
Minoxidil
Diazoxide
Calcium channel blockers
list
WHO-EM
Withdrawn
Clinical trials
Phase III
navbox, sidebar
table with the collapsible attribute
parameter
Category
Drug templates by ATC

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.